Guangdong Taiantang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 139.32 million compared to CNY 191.25 million a year ago. Revenue was CNY 139.32 million compared to CNY 191.25 million a year ago.

Net loss was CNY 61.44 million compared to CNY 37.35 million a year ago. Basic loss per share from continuing operations was CNY 0.08 compared to CNY 0.05 a year ago. Diluted loss per share from continuing operations was CNY 0.08 compared to CNY 0.05 a year ago.